CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$13.06
+0.12 (+0.93%)
Open$12.80
Previous Close$12.94
Day High$13.09
Day Low$12.75
52W High$27.41
52W Low$8.72
Volume—
Avg Volume237.4K
Market Cap480.64M
P/E Ratio—
EPS$-7.41
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+111.8% upside
Current
$13.06
$13.06
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.32M | 57.99M | 51.60M |
| Net Income | -551,112,289 | 180.8K | 210.8K |
| Profit Margin | -1,438.1% | 0.3% | 0.4% |
| EBITDA | -539,118,307 | 390.2K | 358.0K |
| Free Cash Flow | — | 84.1K | 101.4K |
| Rev Growth | +413.7% | +8.6% | +24.1% |
| Debt/Equity | — | 0.52 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |